Longevity Peptides

Russian lung bioregulator marketed for bronchial lining support and respiratory resilience. Public user reports are thin, so the use-case comes mainly from bioregulator literature and vendor positioning.

Heart-focused bioregulator sold for cardiac resilience and tissue support rather than day-to-day 'feeling' effects. Public signal is limited, so this is mostly a longevity-market peptide.

Longevity favorite used for healthy-aging routines, sleep timing, and 'cellular reset' cycles. The science often spotlights telomerase and pineal signaling, but public use is mostly anti-aging and sleep rhythm.

Senolytic-style peptide people discuss for clearing senescent cells and slowing age-related decline. It is firmly experimental, with preclinical longevity appeal far outpacing real-world human evidence.

Mitochondrial longevity peptide people chase for cellular resilience, neuroprotection, and healthier aging. The mechanistic science is intriguing, but public use is still early and mostly biohacker-driven.

Brain-focused bioregulator marketed for memory, neuroprotection, and healthy cognitive aging. Public use is real but small, and much of the narrative comes from Russian longevity literature.

Thymic peptide complex used for immune resilience, recovery, and healthy aging. Compared with Thymosin Alpha-1, it feels more like a classic Eastern European bioregulator than a mainstream peptide.

Vascular bioregulator marketed for circulation, endothelial support, and vascular aging. It is mostly a longevity-shop product, with thin mainstream user-report volume.

Tiny bioregulator peptide associated with immune aging and gene-expression support. Public demand is niche and the evidence base is mostly older bioregulator literature.